Bristol-Myers Squibb (BMY) Earnings Date & Reports
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders... Show more
BMY is expected to report earnings to fall 15.69% to $1.72 per share on October 29
Q3'26
Est.
$1.72
Q2'26
Beat
by $0.43
Q1'26
Beat
by $0.16
Q4'25
Beat
by $0.14
Q3'25
Beat
by $0.11
The last earnings report on July 30 showed earnings per share of $2.04, beating the estimate of $1.61. With 371.43K shares outstanding, the current market capitalization sits at 136.70B.